Why Patient Engagement Matters in HCV

Last week we published a literature review of economic models published on new hepatitis C virus (HCV) treatments over the...

Finding the Right Comparison

Recently, I had the opportunity to work with two strong pharmacoeconomics researchers (Daniel Mullins and Julia Slejko) to develop a...

Setting the 2nd Panel Straight on Discounting

Setting the 2nd Panel Straight on Discounting

A guest post by Mike Paulden, Health Economist from the University of Alberta, and Dr. James F. O’Mahony, Health Economist...

All original content on these pages is fingerprinted and certified by Digiprove